Literature DB >> 20237969

Survival of verapamil-poisoned rats treated with triiodothyronine.

Michael J Lynch1, Kenneth D Katz, Clifton W Callaway, Eric S Logue.   

Abstract

Life-threatening toxicity due to calcium channel blocker ingestion is commonly encountered by emergency medicine physicians and toxicologists. Despite a vast array of research on its treatment, results have proven inconsistent. The goal of this study is to evaluate potential vasopressor effects of triiodothyronine (T3) in rats poisoned with verapamil. Following anesthesia and intubation, ten Sprague-Dawley rats were given intravenous verapamil infusion of 10 mg/kg/h. This dose was titrated until a mean arterial pressure (MAP) of 50-55 mmHg was achieved and maintained for a period of at least 5 min. The verapamil infusion was then maintained at that rate. Five rats were randomized to receive a T3 bolus of 0.4 mcg/kg preceding an infusion of 1.5 mcg/kg/day which was doubled every 2 min until any of the following endpoints: systolic blood pressure of 100 mmHg, an elapsed time of 60 min, or death. The other five received an equal volume of normal saline solution. The primary outcome measure was survival with secondary outcomes of MAP and heart rate. The T3 group did have a slightly longer, yet not statistically significant, average time to cessation of electrical activity-30.0 +/- 14.4 min versus 23.8 +/- 9.5 min in the placebo group. Average MAP decreased nearly identically in the two groups. Heart rates were not reliable indicators of toxicity in this rat model as there was little decrease until immediately prior to death in most animals. Despite significant variability in toxicity among individual animals, no statistically significant difference in survival time, heart rate, or MAP was found between groups treated with T3 and those receiving saline.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20237969      PMCID: PMC3550284          DOI: 10.1007/s13181-010-0016-7

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  20 in total

1.  Intralipid prolongs survival in a rat model of verapamil toxicity.

Authors:  Simon Tebbutt; Martyn Harvey; Tonia Nicholson; Grant Cave
Journal:  Acad Emerg Med       Date:  2006-01-25       Impact factor: 3.451

2.  The role of thyroid hormone administration in potential organ donors.

Authors:  A Salim; P Vassiliu; G C Velmahos; J Sava; J A Murray; H Belzberg; J A Asensio; D Demetriades
Journal:  Arch Surg       Date:  2001-12

3.  Thyroid hormone stimulates Na, K-ATPase gene expression in the hemodynamically unloaded heterotopically transplanted rat heart.

Authors:  Y Shao; K Ojamaa; I Klein; F Ismail-Beigi
Journal:  Thyroid       Date:  2000-09       Impact factor: 6.568

4.  Hemodynamic effects of intravenous fat emulsion in an animal model of severe verapamil toxicity resuscitated with atropine, calcium, and saline.

Authors:  Theodore C Bania; Jason Chu; Eric Perez; Mark Su; In-Hei Hahn
Journal:  Acad Emerg Med       Date:  2007-02       Impact factor: 3.451

Review 5.  Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity.

Authors:  Christopher R DeWitt; Javier C Waksman
Journal:  Toxicol Rev       Date:  2004

6.  Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning.

Authors:  T H Yuan; W P Kerns; C A Tomaszewski; M D Ford; J A Kline
Journal:  J Toxicol Clin Toxicol       Date:  1999

7.  The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function.

Authors:  Athena F Zuppa; Vinay Nadkarni; Lauren Davis; Peter C Adamson; Mark A Helfaer; Michael R Elliott; John Abrams; Dennis Durbin
Journal:  Crit Care Med       Date:  2004-11       Impact factor: 7.598

8.  The effects of 4-aminopyridine and Bay K 8644 on verapamil-induced cardiovascular toxicity in anesthetized rats.

Authors:  Y Tuncok; S Apaydin; A Gelal; M Ates; H Guven
Journal:  J Toxicol Clin Toxicol       Date:  1998

9.  Triiodothyronine reverses depressed contractile performance after excessive catecholamine stimulation.

Authors:  T Timek; C F Vahl; A Bonz; L Schäffer; M Rosenberg; S Hagl
Journal:  Ann Thorac Surg       Date:  1998-11       Impact factor: 4.330

10.  [Characteristics of pharmacological and toxic effects of verapamil during cardiac arrhythmia in thyrotoxic and hypothyroid rats].

Authors:  A E Sokhanenkova; M Iu Sokhanenkov; E Iu Afanas'eva; E V Arzamastsev
Journal:  Kardiologiia       Date:  2008       Impact factor: 0.395

View more
  2 in total

1.  Comparison of Effects of Separate and Combined Sugammadex and Lipid Emulsion Administration on Hemodynamic Parameters and Survival in a Rat Model of Verapamil Toxicity.

Authors:  Serkan Tulgar; Halil Cihan Kose; Isılay Demir Piroglu; Evvah Karakilic; Nagihan Gozde Ates; Ahmet Demir; Ruken Gergerli; Selin Guven; Mustafa Devrim Piroglu
Journal:  Med Sci Monit       Date:  2016-03-25

Review 2.  Treatment for calcium channel blocker poisoning: a systematic review.

Authors:  M St-Onge; P-A Dubé; S Gosselin; C Guimont; J Godwin; P M Archambault; J-M Chauny; A J Frenette; M Darveau; N Le Sage; J Poitras; J Provencher; D N Juurlink; R Blais
Journal:  Clin Toxicol (Phila)       Date:  2014-10-06       Impact factor: 4.467

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.